MIKULÁŠOVÁ, Aneta, Jan SMETANA, Markéta WAYHELOVÁ, Helena JANYŠKOVÁ, Samuel Adeyinka OKUBOTE, Roman HÁJEK and Petr KUGLÍK. Whole genome amplification effect on segmental copy-number changes and copy-number neutral loss of heterozygosity analysis by oligonucleotide-array based comparative genomic hybridization in human myeloma cell line. International Journal of Clinical and Experimental Pathology. 2016, vol. 9, No 7, p. 6965-6980. ISSN 1936-2625.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Whole genome amplification effect on segmental copy-number changes and copy-number neutral loss of heterozygosity analysis by oligonucleotide-array based comparative genomic hybridization in human myeloma cell line
Authors MIKULÁŠOVÁ, Aneta (203 Czech Republic, belonging to the institution), Jan SMETANA (203 Czech Republic, belonging to the institution), Markéta WAYHELOVÁ (203 Czech Republic, belonging to the institution), Helena JANYŠKOVÁ (203 Czech Republic, belonging to the institution), Samuel Adeyinka OKUBOTE (566 Nigeria, belonging to the institution), Roman HÁJEK (203 Czech Republic) and Petr KUGLÍK (203 Czech Republic, guarantor, belonging to the institution).
Edition International Journal of Clinical and Experimental Pathology, 2016, 1936-2625.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.706
RIV identification code RIV/00216224:14310/16:00088952
Organization unit Faculty of Science
UT WoS 000381729200036
Keywords in English whole genome amplification; array-comparative genomic hybridization; copy-number changes
Tags AKR, rivok
Tags International impact, Reviewed
Changed by Changed by: Ing. Andrea Mikešková, učo 137293. Changed: 26/4/2017 23:13.
Abstract
Whole genome amplification (WGA) is an approach designed to overcome small amounts of DNA for genome-wide genetic tests used in many clinical applications. Various strategies of WGA have been developed; however, none of them can guarantee the absence of amplification bias. In this study, a total of 4 multiple displacement amplification (MDA)-based and 2 PCR-based WGA kits were compared in their effect on segmental copy-number (CN) changes and copy-number neutral loss of heterozygosity (cnnLOH) detection by 3 microarray platforms: CGH/4×44 K (Agilent), CGH+SNP/4×180 K (Agilent) and CGH+SNP/4×180 K (OGT). Genomic imbalances-rich myeloma cell line U266 was used as material. The main outcomes are as follows: 1) MDA-based WGAs showed higher tendency to generate false positive imbalances in contrast to PCR-based WGAs with higher risk of false negativity; 2) the specific risk of false positivity and/or negativity increased with decreasing CN segments size; 3) single-cell WGAs showed significantly worse effect on results in comparison to WGAs with nanogram level of DNA as input; 4) PCR-based WGAs were incompatible with cnnLOH analysis based on SNP in restriction digestion sites and also showed higher risk of cnnLOH false negativity when combined with analysis based on simple hybridization. In conclusion, the results of this study help to choose WGA according to individual user requirements and options. Moreover, we have shown a strategy to verify and validate segmental CN changes detection by DNA array protocol including any WGA for any purpose to attain the highest efficiency without an unnecessary WGA bias.
Links
NT13492, research and development projectName: Úloha genetických abnormalit ve vývoji a progresi prekancerózy monoklonální gamapatie nejasného významu
PrintDisplayed: 24/4/2024 22:02